Larry Kaiser, M.D.
President

Susan Coulter, J.D.
Vice President, Office
of Institutional Advancement

Wendy K. Mohon
Editor

Michelle Rexroat
Web Developer I

April, 2005
Table of Contents

Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

 

New

John Y. Choi, Medical School (MS), Memorial Hermann Hospital Telemedicine Network Expansion, Memorial Hermann Hospital System, $406,800.

Thomas O. Clanton, MS, A Prospective, Randomized, Multi- Center Trial Comparing Opteform to Autograft in Ankle Fusion, Extactech Inc., $20,800.

Thomas G. Cleary, MS, In Vitro Effect of Rifaximin on Shiga Toxin E. Coli, Salix Pharmaceuticals Inc., $72,394.

William H. Donovan, MS, Prevention of UTI in Person with Spinal Cord Injury, Baylor College of Medicine, $12,593.

Gerard E. Francisco, MS, Long-Term Safety and Efficacy of Intrathecal Baclofen Therapy in Stroke, Medtroni, Inc., $61,386.

James C. Grotta, MS, tPA Argatroban Stroke Study (TARTS), Glaxo Smith Kline, $65,000.

Adelaide A. Hebert, MS, A Double-Blind, Randomized, Vehicle- Controlled Trial to Determine the Efficacy and Safety of Hydrocortisone Butyrate Lotion 0.1% in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects Aged 3 Months to Less Than 18 Years, Ferndale Laboratories Inc., $43,550; Novel Skin Barrier to Prevent and Treat Poison Ivy, Biomedical Development Corporation, $18,505; and Novel Treatment of Keloids and Hypertrophic Scars, Biomedical Development Corporation, $18,312.

Vasanthi Jayaraman, MS and Graduate School of Biomedical Sciences (GSBS), High Throughput Screening for AMPA Receptor Antagonists for ALS, Muscular Dystrophy Association Inc., $200,000.

Isabelle F. Jeffress, MS, Boosting Car Seat Safety, Memorial Hermann Children's Hospital, $4,000.

Susan Landry, MS, Longitudinal Effects of Spina Bifida on Learning, National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), $2,137,249.

John W. Lindsey, MS and GSBS, Double-Blind, Placebo- Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 Mg B.I.D.) in Subjects with Multiple Sclerosis, Acorda Therapeutics Inc., $71,448.

Marianne T. Marcus, School of Nursing, Consortium for Research in Elder Self-Neglect in Texas (CREST), Baylor College of Medicine, $22,964.

Maria T. Morandi, School of Public Health, Diagnostic Evaluation and Refinement of Procedures for Modeling Exposures to VOCs, University of Medicine and Dentistry of New Jersey, $15,320.

Diane Novy, MS, Treating Late-Life GAD in Primary Care, Baylor College of Medicine, $40,718.

Nehal A. Parikh, MS, Neurological Diseases Research in High Risk Newborns, NIH, National Institute of Neurological Disorders and Stroke (NINDS), $817,076.

Karen Adler Storthz, Dental Branch (DB) and GSBS, Optical Systems for In Vivo Molecular Imaging of Cancer, The University of Texas at Austin, $67,717.

Heinrich Taegtmeyer, MS and GSBS, Molecular Mechanisms of Reverse Remodeling in the Heart During Mechanical Unloading, St. Luke's Episcopal Hospital, $50,000.

Nadarajah Vigneswaran, DB, Emmprin: A Potential Prognostic Marker in Oral Leukoplakia, Texas Medical Center, $14,982.

Noranna B.Warner, MS, Treatment Adherence in Minorities with Rheumatic Disease, Baylor College of Medicine, $5,000.

Yang Xia, MS, Angiotensin Receptor, Autoimmunity and Preclam, NIH, National Heart, Lung, and Blood Institute, $1,039,500.

Renewal

Richard B. Clark, MS and GSBS, Beta Adrenergic Receptor Structure and Desensitization, NIH, National Institute of General Medical Sciences (NIGMS), $1,307,534.

Jack Fletcher, MS, Spina Bifida: Cognitive and Neurobiological Variability, NIH, NICHD, $7,690,456.

Samuel Kaplan, MS and GSBS, Induction and Biogenesis of Subcellular Organelles, NIH, NIGMS, $1,362,947.

John R. Klein, DB and GSBS, Gut-Derived Immune Effector Cells, NIH, National Institute of Diabetes and Digestive and Kidney Diseases, $1,220,850.

Stephen B. Tucker,MS, The Anti-Tumor Effects of Interferon on Squamous Cell Carcinoma, Clayton Foundation for Research, $38,850.

Jerry S.Wolinsky, MS and GSBS, Viral Mimicry and Multiple Sclerosis, Clayton Foundation for Research, $74,346.